Although the exact mechanism for the protective effect of RAAS inhibitor against cancer is not fully known, ACE inhibitors reduce the conversion of angiotensin I to angiotensin II, and ARBs selectively inhibit the unfavorable actions of AT1R by maintaining the protective function of AT2R signaling. The gene discussed is AGTR1; the disease is cancer.